Menu
Back to Journals » Risk Management and Healthcare Policy » Volume 15
Original Research
Cost-Effectiveness Analysis of Gefitinib Alone and Combined with Chemotherapy as First-Line Treatment for Patients with Advanced Non-Small-Cell Lung Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,235 | Dovepress* | 5,912+ | 377 | 6,289 | |
| PubMed Central* | 323 | 139 | 462 | ||
| Totals | 6,235 | 516 | 6,751 | ||
| *Since 1 March 2022 | |||||
View citations on PubMed Central and Google Scholar